Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿

Herb

→

→

→

→

🧪

Evidence

23,295

trials · metas · refs

Plus 6,743 TCM formulas connecting herbs together

Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases

Quick picks: Taxol Oxytocin Morphine (?)-nicotine Testosterone Melatonin Caffeine L-ascorbic acid Progesterone Coumarins

⚗️ Ingredient

Cannabigerol

Open on HERB 2.0 ↗

Clinical Trials

Meta-Analyses

PubMed References

Top Conditions Studied with Cannabigerol

Health, Subjective|Inflammatory Response|Adverse Effect|Side 1 Focus: To Examine Acute Effects of CBG on Anxiety, Stress, a 1 Sleep 1

📋 Sample Trials

NCT05088018

Swallowable Cannabigerol Tablets for Sleep Quality In Veterans (Veterans Exploring Cannabigerol for Sleep)

Completed

NCT05257044

Acute Effects of Cannabigerol

Completed · Phase 1

NCT05743985

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults

Completed

📊 Sample Meta-Analyses

None linked yet.

📚 Sample References

PMID 25252936

Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice

Neurotherapeutics · 2015

PMID 31941059

Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus

Antioxidants (Basel) · 2020

PMID 35297036

Inhibition of sodium conductance by cannabigerol contributes to a reduction of dorsal root ganglion neuron excitability

Br J Pharmacol · 2022

⚗️ All Ingredient data fields for Cannabigerol

⚗️ Identity

Name

Cannabigerol

Aliases / Synonyms

25654-31-3; 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol; Cannabigerol (CBG); 2808-33-5; UNII-J1K406072N; CHEBI:69477; CBG; J1K406072N; CHEMBL497318

🧪 Chemistry

Molecular Weight

316.4850

LogP

6.0657

Drug-likeness

0.429

H-Bond Acceptors

H-Bond Donors

Rotatable Bonds

🔬 Structures

Canonical SMILES

CCCCCC1=CC(=C(C(=C1)O)CC=C(C)CCC=C(C)C)O

Isomeric SMILES

CCCCCC1=CC(=C(C(=C1)O)C/C=C(\C)/CCC=C(C)C)O

InChIKey

QXACEHWTBCFNSA-SFQUDFHCSA-N

InChI

InChI=1S/C21H32O2/c1-5-6-7-11-18-14-20(22)19(21(23)15-18)13-12-17(4)10-8-9-16(2)3/h9,12,14-15,22-23H,5-8,10-11,13H2,1-4H3/b17-12+

🔗 External References

HERB DB

HBIN019565 ↗

PubChem CID

5315659 ↗

CAS Number

25654-31-3 ↗

NPASS

NPC201662

HIT

C1212

TCMID

3081

TCM-ID

5966

🔍 Raw view — every non-empty column on this row (31 fields)

name

Cannabigerol

common names

25654-31-3; 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol; Cannabigerol (CBG); 2808-33-5; UNII-J1K406072N; CHEBI:69477; CBG; J1K406072N; CHEMBL497318

herb ingredient id

HBIN019565

canonical smiles

CCCCCC1=CC(=C(C(=C1)O)CC=C(C)CCC=C(C)C)O

isomeric smiles

CCCCCC1=CC(=C(C(=C1)O)C/C=C(\C)/CCC=C(C)C)O

inchi

InChI=1S/C21H32O2/c1-5-6-7-11-18-14-20(22)19(21(23)15-18)13-12-17(4)10-8-9-16(2)3/h9,12,14-15,22-23H,5-8,10-11,13H2,1-4H3/b17-12+

inchikey

QXACEHWTBCFNSA-SFQUDFHCSA-N

mol wt

316.4850

num h acceptors

num h donors

mol logp

6.0657

num rotatable bonds

drug likeness

0.429

cas id

25654-31-3

tcmid ingredient id

3081

tcm id ingredient id

5966

pubchem cid

5315659

npass id

NPC201662

hit id

C1212

📋 Clinical Trials

3 · subject of clinical study

NCT05088018 Swallowable Cannabigerol Tablets for Sleep Quality In Veterans (Veterans Explori

→ Sleep

NCT05257044 Acute Effects of Cannabigerol

→ Focus: To Examine Acute Effects of CBG on Anxiety,

NCT05743985 Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults

→ Health, Subjective|Inflammatory Response|Adverse E

📚 PubMed References

4 · cited research

PMID 25252936 Neuroprotective properties of cannabigerol in Huntington's disease: studies in R

Neurotherapeutics

PMID 31941059 Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabige

Antioxidants (Basel)

PMID 35297036 Inhibition of sodium conductance by cannabigerol contributes to a reduction of d

Br J Pharmacol

PMID 35740979 Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Dive

Biomolecules

How relationships are computed

Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
Target ↔ Disease: ACTIVE — direct link via target_health_topics
Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables